Literature DB >> 7565136

Immunogenicity of multiple antigen peptides containing Plasmodium vivax CS epitopes in BALB/c mice.

M A Herrera1, C de Plata, J M González, G Corradin, S Herrera.   

Abstract

Multiple antigen peptide systems (MAPs) allow the incorporation of various epitopes in to a single synthetic peptide immunogen. We have characterized the immune response of BALB/c mice to a series of MAPs assembled with different B and T cell epitopes derived from the Plasmodium vivax circumsporozoite (CS) protein. A B-cell epitope from the central repeat domain and two T-cell epitopes from the amino and carboxyl flanking regions were used to assembled eight different MAPs. An additional universal T cell epitope (ptt-30) from tetanus toxin protein was included. Immunogenicity in terms of antibody responses and in vitro T lymphocyte proliferation was evaluated. MAPs containing B and T cell epitopes induced high titers of anti-peptides antibodies, which recognized the native protein on sporozoites as determined by IFAT. The antibody specificity was also determined by a competitive inhibition assay with different MAPs. A MAP containing the B cell epitope (p11) and the universal epitope ptt-30 together with another composed of p11 and the promiscuous T cell epitope (p25) proved to be the most immunogenic. The strong antibody response and specificity for the cognate protein indicates that further studies designed to assess the potential of these proteins as human malaria vaccine candidates are warranted.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7565136     DOI: 10.1590/s0074-02761994000600017

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  4 in total

1.  Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.

Authors:  M B Joshi; A A Gam; R A Boykins; S Kumar; J Sacci; S L Hoffman; H L Nakhasi; R T Kenney
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Promiscuous T-cell epitopes of Plasmodium merozoite surface protein 9 (PvMSP9) induces IFN-gamma and IL-4 responses in individuals naturally exposed to malaria in the Brazilian Amazon.

Authors:  J C Lima-Junior; D M Banic; T M Tran; V S E Meyer; S G De-Simone; F Santos; L C S Porto; M T Q Marques; A Moreno; J W Barnwell; M R Galinski; J Oliveira-Ferreira
Journal:  Vaccine       Date:  2010-02-26       Impact factor: 3.641

Review 3.  Major Histocompatibility Complex and Malaria: Focus on Plasmodium vivax Infection.

Authors:  Josué da Costa Lima-Junior; Lilian Rose Pratt-Riccio
Journal:  Front Immunol       Date:  2016-01-27       Impact factor: 7.561

4.  A VLP for validation of the Plasmodium falciparum circumsporozoite protein junctional epitope for vaccine development.

Authors:  Erwan Atcheson; Adrian V S Hill; Arturo Reyes-Sandoval
Journal:  NPJ Vaccines       Date:  2021-04-01       Impact factor: 7.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.